SLC27A2 Polyclonal Antibody

Cat.#: 160607

Special Price 174.2 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    SLC27A2 Polyclonal Antibody
  • Documents
  • Description
    Polyclonal antibody to SLC27A2
  • Tested applications
    WB, IHC
  • Species reactivity
    Human, Mouse
  • Alternative names
    SLC27A2 antibody; ACSVL1 antibody; FACVL1 antibody; FATP2 antibody; HsT17226 antibody; VLACS antibody; VLCS antibody; hFACVL1 antibody; solute carrier family 27 member 2 antibody
  • Isotype
    Rabbit IgG
  • Preparation
    Antigen: Recombinant fusion protein containing a sequence corresponding to amino acids 30-200 of human SLC27A2 (NP_001153101.1).
  • Clonality
    Polyclonal
  • Formulation
    PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
  • Storage instructions
    Store at -20℃. Avoid freeze / thaw cycles.
  • Applications
    WB 1:500 - 1:2000
    IHC 1:50 - 1:200
  • Validations

    Western blot - SLC27A2 Polyclonal Antibody

    Western blot - SLC27A2 Polyclonal Antibody

    Western blot analysis of extracts of HepG2 cells, using SLC27A2 antibody .Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.

    Immunohistochemistry - SLC27A2 Polyclonal Antibody

    Immunohistochemistry - SLC27A2 Polyclonal Antibody

    Immunohistochemistry of paraffin-embedded human liver using SLC27A2 antibody at dilution of 1:100 (40x lens).

    Immunohistochemistry - SLC27A2 Polyclonal Antibody

    Immunohistochemistry - SLC27A2 Polyclonal Antibody

    Immunohistochemistry of paraffin-embedded human gastric cancer using SLC27A2 antibody at dilution of 1:100 (40x lens).

  • Background
    Acyl-CoA synthetase probably involved in bile acid metabolism. Proposed to activate C27 precursors of bile acids to their CoA thioesters derivatives before side chain cleavage via peroxisomal beta-oxidation occurs. In vitro, activates 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanate (THCA), the C27 precursor of cholic acid deriving from the de novo synthesis from cholesterol. Does not utilize C24 bile acids as substrates. In vitro, also activates long- and branched-chain fatty acids and may have additional roles in fatty acid metabolism. May be involved in translocation of long-chain fatty acids (LFCA) across membranes (By similarity).

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"